Results 131 to 140 of about 361,079 (214)

Complicated pneumococcal pneumonia in the era of higher-valent pneumococcal conjugate vaccines: a systematic literature review and meta-analysis, 2001-2022. [PDF]

Eur J Clin Microbiol Infect Dis
Fletcher MA, Okasha O, Baay M, Syrochkina M, Hayford K.   +4 more
europepmc   +1 more source

Population snapshot of <i>Streptococcus pneumoniae</i> causing invasive disease among adults aged ≥18 years in South Africa before and after implementation of pneumococcal conjugate vaccines in 2005-2020. [PDF]

Microb Genom
Ndlangisa KM, Lekhuleni C, Skosana H, de Gouveia L, Meiring S, Walaza S, Quan V, Bentley SD, Lo SW, Cohen C, von Gottberg A, du Plessis M.   +11 more
europepmc   +1 more source

Pneumococcal conjugate vaccine and pneumococcal common protein vaccines

, 2013
Keith P. Klugman, Steven Black, Ron Dagan, Richard Malley, Cynthia G. Whitney   +4 more
openaire   +1 more source

Correction to: The Complex Landscape of Updated Pneumococcal Conjugate Vaccines. [PDF]

Open Forum Infect Dis
europepmc   +1 more source

Effect of Pneumococcal Conjugate Vaccines on Viral Respiratory Infections: A Systematic Literature Review. [PDF]

J Infect Dis
Sepúlveda-Pachón IT, Dunne EM, Hanquet G, Baay M, Menon S, Jodar L, Gessner BD, Theilacker C.   +7 more
europepmc   +1 more source

III. Characteristics and Differences in Pneumococcal Vaccines; 2. Pneumococcal Conjugate Vaccine

Nihon Naika Gakkai Zasshi, 2015
openaire   +3 more sources

Comparison of 13-, 15- and 20-valent pneumococcal conjugate vaccines in the paediatric Canadian population: A cost-utility analysis. [PDF]

Can Commun Dis Rep
Simmons AE, Gebretekle GB, Pless R, Wierzbowski A, Tunis M, Tuite AR.   +5 more
europepmc   +1 more source

Invasive Pneumococcal Disease and Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines in Singapore Children Over 24 Years. [PDF]

Open Forum Infect Dis
Li J, Yung CF, Kam KQ, Nadua K, Tan NWH, Thoon KC, Maiwald M, Chong CY.   +7 more
europepmc   +1 more source

Global impact of 10- and 13-valent pneumococcal conjugate vaccines on pneumococcal meningitis in all ages: The PSERENADE project. [PDF]

J Infect
Yang Y, Knoll MD, Herbert C, Bennett JC, Feikin DR, Garcia Quesada M, Hetrich MK, Zeger SL, Kagucia EW, Xiao M, Cohen AL, van der Linden M, du Plessis M, Yildirim I, Winje BA, Varon E, Valenzuela MT, Valentiner-Branth P, Steens A, Scott JA, Savrasova L, Sanz JC, Khan AS, Oishi K, Nzoyikorera N, Nuorti JP, Mereckiene J, McMahon K, McGeer A, Mackenzie GA, MacDonald L, Ladhani SN, Kristinsson KG, Kleynhans J, Kellner JD, Jayasinghe S, Ho PL, Hilty M, Hammitt LL, Guevara M, Gilkison C, Gierke R, Desmet S, De Wals P, Dagan R, Colzani E, Ciruela P, Chuluunbat U, Chan G, Camilli R, Bruce MG, Brandileone MC, Ampofo K, O'Brien KL, Hayford K, PSERENADE Team.   +55 more
europepmc   +1 more source

Understanding healthcare providers' preferred attributes of pediatric pneumococcal conjugate vaccines in the United States. [PDF]

Hum Vaccin Immunother
Mohanty S, Tsai JH, Ning N, Martinez A, Verma RP, Heisen M, Weaver J, Feemster KA, Chun B, Weiss TW, Schmier JK.   +10 more
europepmc   +1 more source